Esophagitis

·MeSH: Esophagitis

31 drugs in development·19 companies·1 clinical trial

Drug Pipeline by Phase

Approved(15)

Drug	Company
dexlansoprazole	Mylan II B.V. (MYL)
esomeprazole magnesium	SUNSET ISLAND GROUP (SUN)
esomeprazole magnesium	LANNETT CO INC (LCI)
esomeprazole magnesium	Mylan II B.V. (MYL)
esomeprazole magnesium	EXELIXIS, INC. (EXEL)
famotidine	Mersana Therapeutics, Inc. (MRSN)
famotidine	ENGENE HOLDINGS INC. (ENGN)
famotidine	Avita Medical Inc. (RCEL)
famotidine	Miromatrix Medical Inc. (MIRO)
famotidine	Seagen Inc. (SGEN)
famotidine	SUNSET ISLAND GROUP (SUN)
gelfoam plus hemostatic kit	PFIZER INC (PFE)
nexium	ASTRAZENECA PLC (AZN)
pantoprazole	EXELIXIS, INC. (EXEL)
pantoprazole	SUNSET ISLAND GROUP (SUN)

Phase 3(9)

Drug	Company
barzolvolimab	Celldex Therapeutics, Inc. (CLDX)
Barzolvolimab (CDX-0159)	Celldex Therapeutics, Inc. (CLDX)
d961h	ASTRAZENECA PLC (AZN)
d961h	ASTRAZENECA PLC (AZN)
d961h sachet	ASTRAZENECA PLC (AZN)
Vonoprazan	Phathom Pharmaceuticals, Inc. (PHAT)
vonoprazan (VOQUEZNA)	Phathom Pharmaceuticals, Inc. (PHAT)
vonoprazan (VOQUEZNA) - as-needed regimen	Phathom Pharmaceuticals, Inc. (PHAT)
vonoprazan (VOQUEZNA) - EoE	Phathom Pharmaceuticals, Inc. (PHAT)

Phase 2(3)

Drug	Company
Dabrafenib plus Trametinib	PFIZER INC (PFE)
etrasimod	ARENA PHARMACEUTICALS INC (ARNA)
zumilokibart	Apogee Therapeutics, Inc. (APGE)

Phase 1(2)

Drug	Company
ANB033	ANAPTYSBIO, INC (ANAB)
Dupilumab	REGENERON PHARMACEUTICALS, INC. (REGN)

Unknown(1)

Drug	Company
vonoprazan	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)

Phase 1/Phase 2(1)

Drug	Company
ep-104gi	EUPRAXIA PHARMACEUTICALS INC. (EPRX)

BioSniper tracks 31 drugs in development for Esophagitis across 19 companies.

There are 1 clinical trial targeting Esophagitis tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.